All News #Library
Rare Diseases
Sol-Gel Updates On SGT-210 Phase 1B Study In Darier Disease
17 Dec 2025 //
GLOBENEWSWIRE
BridgeBio company sells off rare disease candidate to Galderma partner
28 Jan 2023 //
ENDPTS
Sol-Gel Acquires Patidegib, a PIII, FDA Orphan Product Candidate
27 Jan 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support